Heartflow (HTFL) EPS (Weighted Average and Diluted) (2024 - 2025)
Heartflow (HTFL) recorded quarterly EPS (Weighted Average and Diluted) of $1.3 in Q4 2025, up 225.0% quarter-over-quarter from -$1.04 in Q3 2025, and up 122.65% on a YoY basis from $0.58 in Q4 2024.
Heartflow (HTFL) EPS (Weighted Average and Diluted) (2024 - 2025) Analysis & Trends
Heartflow's EPS (Weighted Average and Diluted) history runs 2 years deep, the most recent figure standing at $1.3 for Q4 2025.
- In Q4 2025, EPS (Weighted Average and Diluted) rose 122.65% year-over-year to $1.3; the TTM figure through Dec 2025 stood at -$6.94 (down 277.86% YoY), while the FY2025 annual figure was -$3.17, up 82.37% from the prior year.
- EPS (Weighted Average and Diluted) was $1.3 for Q4 2025 at Heartflow, up from -$1.04 in the prior quarter.
- In the past five years, EPS (Weighted Average and Diluted) ranged from a high of $1.3 in Q4 2025 to a low of -$5.74 in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Weighted Avg. Diluted) (Qtr) |
|---|---|---|---|---|---|
| 1 | Veeva Systems | 24.83 Bn | 17.52 Bn | 662.02 Mn | 1.57 |
| 2 | BrightSpring Health Services | 13.57 Bn | 12.69 Bn | 482.22 Mn | 0.67 |
| 3 | Healthequity | 7.20 Bn | 6.93 Bn | 256.31 Mn | 0.82 |
| 4 | Hinge Health | 5.42 Bn | 5.11 Bn | 154.23 Mn | 0.41 |
| 5 | 10x Genomics | 4.46 Bn | 3.92 Bn | 106.18 Mn | -0.10 |
| 6 | Doximity | 3.81 Bn | 3.06 Bn | 125.97 Mn | 0.10 |
| 7 | Waystar Holding | 3.52 Bn | 3.36 Bn | 268.04 Mn | 0.22 |
| 8 | Privia Health | 2.94 Bn | 2.57 Bn | 595.71 Mn | 0.02 |
| 9 | Omnicell | 1.76 Bn | 1.59 Bn | 140.36 Mn | 0.25 |
| 10 | Heartflow | 1.24 Bn | 1.06 Bn | 39.06 Mn | 1.30 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 1.30 |
| Sep 30, 2025 | -1.04 |
| Jun 30, 2025 | -1.46 |
| Dec 31, 2024 | -5.74 |
| Sep 30, 2024 | -3.43 |
| Jun 30, 2024 | -4.66 |